Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Chinese researchers find key neuron of stress coping strategies
Chinese researchers find key neuron of stress coping strategies
BEIJING, March 11 (Xinhua) -- To "fight or flight" in stressful conditions, is a well-known scientific question.
Bora Pharmaceuticals to acquire GSK Mississauga-based Facility
Bora Pharmaceuticals to acquire GSK Mississauga-based Facility
Mississauga, ON, March 10, 2020 – Bora Pharmaceuticals Co.
Gates-funded project to offer home-testing kits for coronavirus
Gates-funded project to offer home-testing kits for coronavirus
SAN FRANCISCO, March 10 (Xinhua) -- A project funded by Bill Gates and his foundation will soon begin to offer home-testing kits that allow people who fear they may be infected with the corona...
FDA Approves New Treatment for Adults with Cushing’s Disease
FDA Approves New Treatment for Adults with Cushing’s Disease
The U.
New figures show 3.5 million unlicensed erection pills seized in 2019
New figures show 3.5 million unlicensed erection pills seized in 2019
Around 3.
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
LONDON, March 6, 2020 /CNW/ - ADVANZ PHARMA Corp.
FDA Approves First Treatment for Group of Progressive Interstitial Lung Diseases
FDA Approves First Treatment for Group of Progressive Interstitial Lung Diseases
The U.
Pharming gets FDA approval for new facility to make HAE drug Ruconest
Pharming gets FDA approval for new facility to make HAE drug Ruconest
Pharming Group last year took back control of Ruconest, its treatment for protein deficiency hereditary angioedema (HAE).
World Vaccines Market Outlook to 2030: Major Players are AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck and Pfizer
World Vaccines Market Outlook to 2030: Major Players are AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck and Pfizer
DUBLIN, March 5, 2020 /PRNewswire/ -- The "Vaccines Global Market Report 2020" report has been added to ResearchAndMarkets.
FDA Requires Stronger Warning About Risk of Neuropsychiatric Events Associated with Asthma and Allergy Medication Singulair and Generic Montelukast
FDA Requires Stronger Warning About Risk of Neuropsychiatric Events Associated with Asthma and Allergy Medication Singulair and Generic Montelukast
The U.
Thermo Fisher Scientific to Acquire QIAGEN N.V.
Thermo Fisher Scientific to Acquire QIAGEN N.V.
WALTHAM, Mass.
Urovant Sciences announces US FDA acceptance of NDA for Vibegron to treat overactive bladder
Urovant Sciences announces US FDA acceptance of NDA for Vibegron to treat overactive bladder
Urovant Sciences announced that the US Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for once-daily 75 mg vibegron for the treat...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand